Recursion Pharmaceuticals: Fourth Quarter Financial Highlights

Recursion Pharmaceuticals Reports Fourth Quarter Financial Results

Recursion Pharmaceuticals Inc., headquartered in Salt Lake City, announced on Wednesday that it recorded a net loss of $108.1 million for the fourth quarter.

The company’s quarterly loss amounted to $0.21 per share.

Despite the loss, Recursion outperformed analysts’ expectations. According to Zacks Investment Research, three analysts had predicted a loss of $0.28 per share on average.

During the same period, the biotechnology firm generated $35.5 million in revenue, exceeding the $25.5 million anticipated by four analysts surveyed by Zacks.

For the full year, Recursion reported a total loss of $644.8 million, or $1.44 per share, with annual revenue reaching $74.7 million.